Literature DB >> 15709119

Clinical and imaging outcomes after stroke with normal angiograms.

Andrew P Slivka1, Greg A Christoforidis, Eric C Bourekas, Philip E Calendine, Margaret A Notestine.   

Abstract

BACKGROUND AND
PURPOSE: Information about the prognosis of patients with acute ischemic stroke and normal angiography is limited. We report clinical and imaging outcomes of patients seen within 6 hours of symptom onset who were considered candidates for thrombolysis.
METHODS: Between November 1994 and December 1999, patients with stroke onset of less than 6 hours who were thrombolytic candidates underwent cerebral angiography. Patients with normal angiograms (defined as no sign of occlusive disease in the head or neck in the symptomatic artery) were included. Admission National Institutes of Health Stroke Scale (NIHSS) scores and discharge modified Rankin scores (mRS) were obtained. CT or MR images were obtained 24 hours or longer after symptom onset. Good outcome was defined as an mRS score < or =2. For analysis, follow-up CT or MR imaging findings were classified as showing cortical infarct, subcortical infarct > or =1.5 cm, subcortical infarct < or =1.5 cm, or no new infarct. The mechanism of the normal angiogram was assumed on the basis of these results.
RESULTS: Twenty-one patients with stroke had normal angiograms. About 43% (9/21) of the patients had a favorable hospital discharge clinical outcome, and an additional 33% (7/21) had favorable clinical outcomes at subsequent follow-up. New infarct on follow-up imaging was seen in 71% (15/21). Discharge mRS scores were not correlated with admission NIHSS scores or the mechanism of the normal angiogram.
CONCLUSION: Approximately 76% of acute stroke patients with normal angiograms have a favorable clinical outcome, and 71% have associated new infarctions. Given these outcomes, further study is needed before recommendations regarding thrombolytic treatment can be made in this population.

Entities:  

Mesh:

Year:  2005        PMID: 15709119      PMCID: PMC7974110     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  8 in total

1.  Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism.

Authors:  A Furlan; R Higashida; L Wechsler; M Gent; H Rowley; C Kase; M Pessin; A Ahuja; F Callahan; W M Clark; F Silver; F Rivera
Journal:  JAMA       Date:  1999-12-01       Impact factor: 56.272

2.  Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke.

Authors:  G J del Zoppo; K Poeck; M S Pessin; S M Wolpert; A J Furlan; A Ferbert; M J Alberts; J A Zivin; L Wechsler; O Busse
Journal:  Ann Neurol       Date:  1992-07       Impact factor: 10.422

3.  The arterial lesions underlying lacunes.

Authors:  C M Fisher
Journal:  Acta Neuropathol       Date:  1968-12-18       Impact factor: 17.088

4.  Combined intravenous and intra-arterial r-TPA versus intra-arterial therapy of acute ischemic stroke: Emergency Management of Stroke (EMS) Bridging Trial.

Authors:  C A Lewandowski; M Frankel; T A Tomsick; J Broderick; J Frey; W Clark; S Starkman; J Grotta; J Spilker; J Khoury; T Brott
Journal:  Stroke       Date:  1999-12       Impact factor: 7.914

5.  Outcome of stroke patients without angiographically revealed arterial occlusion within four hours of symptom onset.

Authors:  L Derex; T A Tomsick; T G Brott; C A Lewandowski; M R Frankel; W Clark; S Starkman; J Spilker; G J Udsten; J Khoury; J C Grotta; J P Broderick
Journal:  AJNR Am J Neuroradiol       Date:  2001-04       Impact factor: 3.825

6.  PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT Investigators. Prolyse in Acute Cerebral Thromboembolism.

Authors:  G J del Zoppo; R T Higashida; A J Furlan; M S Pessin; H A Rowley; M Gent
Journal:  Stroke       Date:  1998-01       Impact factor: 7.914

7.  Capsular infarcts: the underlying vascular lesions.

Authors:  C M Fisher
Journal:  Arch Neurol       Date:  1979-02

8.  Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.

Authors:  H P Adams; B H Bendixen; L J Kappelle; J Biller; B B Love; D L Gordon; E E Marsh
Journal:  Stroke       Date:  1993-01       Impact factor: 7.914

  8 in total
  2 in total

1.  Hemorrhage rates and outcomes when using up to 100 mg intra-arterial t-PA for thrombolysis in acute ischemic stroke.

Authors:  G A Christoforidis; A P Slivka; C Karakasis; Y Mohammad; B Avutu; M Yang; E C Bourekas; D W Chakeres; H W Slone; W T Yuk
Journal:  Interv Neuroradiol       Date:  2010-10-25       Impact factor: 1.610

2.  Clinical and radiological outcomes of acute ischemic stroke patients without angiographic occlusion on digital subtraction angiogram. A pooled analysis of case series.

Authors:  Qaisar A Shah; Muhammad Zeeshan Memon; Gabriela Vazquez; M Fareed K Suri; Haitham M Hussein; Yousef M Mohammad; Adnan I Qureshi
Journal:  Neuroradiology       Date:  2008-09-03       Impact factor: 2.804

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.